These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8151460)

  • 1. Neurofibromatosis type 1: the cognitive phenotype.
    Hofman KJ; Harris EL; Bryan RN; Denckla MB
    J Pediatr; 1994 Apr; 124(4):S1-8. PubMed ID: 8151460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.
    Denckla MB; Hofman K; Mazzocco MM; Melhem E; Reiss AL; Bryan RN; Harris EL; Lee J; Cox CS; Schuerholz LJ
    Am J Med Genet; 1996 Feb; 67(1):98-102. PubMed ID: 8678124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1 in childhood: a study of the neuropsychological profile in 45 children.
    Legius E; Descheemaeker MJ; Spaepen A; Casaer P; Fryns JP
    Genet Couns; 1994; 5(1):51-60. PubMed ID: 8031536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities.
    North K; Joy P; Yuille D; Cocks N; Mobbs E; Hutchins P; McHugh K; de Silva M
    Neurology; 1994 May; 44(5):878-83. PubMed ID: 8190291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Support for an independent familial segregation of executive and intelligence endophenotypes in ADHD families.
    Rommelse NN; Altink ME; Oosterlaan J; Buschgens CJ; Buitelaar J; Sergeant JA
    Psychol Med; 2008 Nov; 38(11):1595-606. PubMed ID: 18261248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive deficits in neurofibromatosis 1.
    North K; Hyman S; Barton B
    J Child Neurol; 2002 Aug; 17(8):605-12; discussion 627-9, 646-51. PubMed ID: 12403559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How children with neurofibromatosis type 1 differ from "typical" learning disabled clinic attenders: nonverbal learning disabilities revisited.
    Cutting LE; Koth CW; Denckla MB
    Dev Neuropsychol; 2000; 17(1):29-47. PubMed ID: 10916573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functions in neurofibromatosis type 1 patients and unaffected siblings.
    Erdoğan-Bakar E; Cinbiş M; Ozyürek H; Kiriş N; Altunbaşak S; Anlar B
    Turk J Pediatr; 2009; 51(6):565-71. PubMed ID: 20196390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of planum temporale and planum parietale morphologic features in neurofibromatosis type 1.
    Billingsley RL; Schrimsher GW; Jackson EF; Slopis JM; Moore BD
    Arch Neurol; 2002 Apr; 59(4):616-22. PubMed ID: 11939897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Review and Meta-analysis of the Intellectual Integrity of Children with Neurofibromatosis Type 1.
    Al-Farsi FAH; Al-Alyani OBS; Al-Kumzari A; Al-Saadi T
    World Neurosurg; 2022 Jan; 157():69-74. PubMed ID: 34648986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder.
    Hyman SL; Arthur Shores E; North KN
    Dev Med Child Neurol; 2006 Dec; 48(12):973-7. PubMed ID: 17109785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning problems in neurofibromatosis patients.
    Stine SB; Adams WV
    Clin Orthop Relat Res; 1989 Aug; (245):43-8. PubMed ID: 2502350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learning disability subtypes in children with neurofibromatosis.
    Brewer VR; Moore BD; Hiscock M
    J Learn Disabil; 1997; 30(5):521-33. PubMed ID: 9293234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth curve analyses of neuropsychological profiles in children with neurofibromatosis type 1: specific cognitive tests remain "spared" and "impaired" over time.
    Cutting LE; Huang GH; Zeger S; Koth CW; Thompson RE; Denckl MB
    J Int Neuropsychol Soc; 2002 Sep; 8(6):838-46. PubMed ID: 12240748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of neurofibromatosis type 1 and attention deficit hyperactivity disorder.
    Koth CW; Cutting LE; Denckla MB
    Child Neuropsychol; 2000 Sep; 6(3):185-94. PubMed ID: 11402396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis.
    Moore BD; Slopis JM; Schomer D; Jackson EF; Levy BM
    Neurology; 1996 Jun; 46(6):1660-8. PubMed ID: 8649566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children and adolescents with neurofibromatosis 1: a behavioral phenotype.
    Dilts CV; Carey JC; Kircher JC; Hoffman RO; Creel D; Ward K; Clark E; Leonard CO
    J Dev Behav Pediatr; 1996 Aug; 17(4):229-39. PubMed ID: 8856518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.
    Hyman SL; Gill DS; Shores EA; Steinberg A; North KN
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1088-91. PubMed ID: 17299016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls.
    Eldridge R; Denckla MB; Bien E; Myers S; Kaiser-Kupfer MI; Pikus A; Schlesinger SL; Parry DM; Dambrosia JM; Zasloff MA
    Am J Dis Child; 1989 Jul; 143(7):833-7. PubMed ID: 2500844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.